Teladoc Health Reports Fourth-Quarter and Full-Year 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Teladoc (TDOC) PT Lowered to $70 at Cantor Fitzgerald
February 28, 2019 9:00 AM ESTCantor Fitzgerald analyst Steven Halper lowered the price target on Teladoc (NYSE: TDOC) to $70.00 (from $83.00) while maintaining a Neutral rating following the company's 4Q earnings report. Revenue was $123M vs. consensus of $120M. Adjusted EBITDA was $5.8M vs. $2.4M a year... More
